96 related articles for article (PubMed ID: 30315757)
1. Additional molecular and clinical evidence open the way to definitive IARC classification of the BRCA1 c.5332G > A (p.Asp1778Asn) variant.
Minucci A; Lalle M; De Leo R; Mazzuccato G; Scambia G; Urbani A; Fagotti A; Concolino P; Capoluongo E
Clin Biochem; 2019 Jan; 63():54-58. PubMed ID: 30315757
[TBL] [Abstract][Full Text] [Related]
2. Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic.
Ahlborn LB; Dandanell M; Steffensen AY; Jønson L; Nielsen FC; Hansen TV
Breast Cancer Res Treat; 2015 Apr; 150(2):289-98. PubMed ID: 25724305
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel germline BRCA1 splice variant, c.5332+4delA.
Yang C; Jairam S; Amoroso KA; Robson ME; Walsh MF; Zhang L
Breast Cancer Res Treat; 2018 Apr; 168(2):543-550. PubMed ID: 29185120
[TBL] [Abstract][Full Text] [Related]
4. The c.5242C>A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding.
Millevoi S; Bernat S; Telly D; Fouque F; Gladieff L; Favre G; Vagner S; Toulas C
Breast Cancer Res Treat; 2010 Apr; 120(2):391-9. PubMed ID: 19404736
[TBL] [Abstract][Full Text] [Related]
5. The BRCA1 c.5434C->G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements.
Gaildrat P; Krieger S; Théry JC; Killian A; Rousselin A; Berthet P; Frébourg T; Hardouin A; Martins A; Tosi M
J Med Genet; 2010 Jun; 47(6):398-403. PubMed ID: 20522429
[TBL] [Abstract][Full Text] [Related]
6. Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.
de la Hoya M; Soukarieh O; López-Perolio I; Vega A; Walker LC; van Ierland Y; Baralle D; Santamariña M; Lattimore V; Wijnen J; Whiley P; Blanco A; Raponi M; Hauke J; Wappenschmidt B; Becker A; Hansen TV; Behar R; Investigators K; Niederacher D; Arnold N; Dworniczak B; Steinemann D; Faust U; Rubinstein W; Hulick PJ; Houdayer C; Caputo SM; Castera L; Pesaran T; Chao E; Brewer C; Southey MC; van Asperen CJ; Singer CF; Sullivan J; Poplawski N; Mai P; Peto J; Johnson N; Burwinkel B; Surowy H; Bojesen SE; Flyger H; Lindblom A; Margolin S; Chang-Claude J; Rudolph A; Radice P; Galastri L; Olson JE; Hallberg E; Giles GG; Milne RL; Andrulis IL; Glendon G; Hall P; Czene K; Blows F; Shah M; Wang Q; Dennis J; Michailidou K; McGuffog L; Bolla MK; Antoniou AC; Easton DF; Couch FJ; Tavtigian S; Vreeswijk MP; Parsons M; Meeks HD; Martins A; Goldgar DE; Spurdle AB
Hum Mol Genet; 2016 Jun; 25(11):2256-2268. PubMed ID: 27008870
[TBL] [Abstract][Full Text] [Related]
7. Germline variant of
Saita C; Aruga T; Adachi M; Kumaki Y; Iwamoto N; Yonekura R; Nakatsugawa N; Inokuchi T; Ishiba T; Honda Y; Yamaguchi T
Int Cancer Conf J; 2022 Jan; 11(1):12-16. PubMed ID: 35127315
[TBL] [Abstract][Full Text] [Related]
8. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.
Lovelock PK; Healey S; Au W; Sum EY; Tesoriero A; Wong EM; Hinson S; Brinkworth R; Bekessy A; Diez O; Izatt L; Solomon E; Jenkins M; Renard H; Hopper J; Waring P; Tavtigian SV; Goldgar D; Lindeman GJ; Visvader JE; Couch FJ; Henderson BR; Southey M; Chenevix-Trench G; Spurdle AB; Brown MA;
J Med Genet; 2006 Jan; 43(1):74-83. PubMed ID: 15923272
[TBL] [Abstract][Full Text] [Related]
9. Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis.
Minucci A; Mazzuccato G; D'Indinosante M; Di Nardo L; Concolino P; De Bonis M; Urbani A; Scambia G; Fagotti A; Capoluongo E
Mol Biol Rep; 2020 Feb; 47(2):1513-1520. PubMed ID: 31833030
[TBL] [Abstract][Full Text] [Related]
10. RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1.
Sharp A; Pichert G; Lucassen A; Eccles D
Hum Mutat; 2004 Sep; 24(3):272. PubMed ID: 15300854
[TBL] [Abstract][Full Text] [Related]
11. Loss of Heterozygosity in BRCA1 and BRCA2 Genes in Patients with Ovarian Cancer and Probability of Its Use for Clinical Classification of Variations.
Kechin AA; Boyarskikh UA; Ermolenko NA; Tyulyandina AS; Lazareva DG; Avdalyan AM; Tyulyandin SA; Kushlinskii NE; Filipenko ML
Bull Exp Biol Med; 2018 May; 165(1):94-100. PubMed ID: 29797126
[TBL] [Abstract][Full Text] [Related]
12. The intronic BRCA1 c.5407-25T>A variant causing partly skipping of exon 23-a likely pathogenic variant with reduced penetrance?
Høberg-Vetti H; Ognedal E; Buisson A; Vamre TBA; Ariansen S; Hoover JM; Eide GE; Houge G; Fiskerstrand T; Haukanes BI; Bjorvatn C; Knappskog PM
Eur J Hum Genet; 2020 Aug; 28(8):1078-1086. PubMed ID: 32203205
[TBL] [Abstract][Full Text] [Related]
13. Study of BRCA1 gene in hereditary breast and ovarian cancer.
Xiaoman D; Jinghe L
Chin Med Sci J; 1999 Dec; 14(4):195-9. PubMed ID: 12894890
[TBL] [Abstract][Full Text] [Related]
14. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M
J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508
[TBL] [Abstract][Full Text] [Related]
15. RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain.
Campos B; Díez O; Domènech M; Baena M; Balmaña J; Sanz J; Ramírez A; Alonso C; Baiget M
Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955719
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 R71K missense mutation contributes to cancer predisposition by increasing alternative transcript levels.
Zhang L; Chen L; Bacares R; Ruggeri JM; Somar J; Kemel Y; Stadler ZK; Offit K
Breast Cancer Res Treat; 2011 Dec; 130(3):1051-6. PubMed ID: 21863257
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of BRCA1 gene variants by mini-gene splicing assay.
Steffensen AY; Dandanell M; Jønson L; Ejlertsen B; Gerdes AM; Nielsen FC; Hansen Tv
Eur J Hum Genet; 2014 Dec; 22(12):1362-8. PubMed ID: 24667779
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of unclassified variants in the BRCA1/2 genes with a putative effect on splicing.
Brandão RD; van Roozendaal K; Tserpelis D; Gómez García E; Blok MJ
Breast Cancer Res Treat; 2011 Oct; 129(3):971-82. PubMed ID: 21638052
[TBL] [Abstract][Full Text] [Related]
19. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotype.
Zuntini R; Cortesi L; Calistri D; Pippucci T; Martelli PL; Casadio R; Capizzi E; Santini D; Miccoli S; Medici V; Danesi R; Marchi I; Zampiga V; Fiorentino M; Ferrari S; Turchetti D
Oncotarget; 2017 Apr; 8(14):22640-22648. PubMed ID: 28186987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
